Health Care (CNBC)
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
9 hours 17 minutes ago
Checkout newsNeuralink competitor Paradromics secures investment from Saudi Arabia's Neom
Paradromics has formed a strategic partnership with Saudi Arabia's Neom
10 hours 56 minutes ago
Checkout newsApple launches first major health study in 5 years. Here's how you can opt in
Apple launched the new project called Apple Health Study with Brigham and Women's Hospital.
11 hours 2 minutes ago
Checkout newsHealthy Returns: What to know about Trump's NIH funding cuts
Here's what to know about Donald Trump’s NIH funding cuts. Americans are struggling with rising costs and high anxiety around reproductive care, a report says.
11 hours 30 minutes ago
Checkout newsCVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled interest in cracking down on PBMs.
11 hours 36 minutes ago
Checkout newsBiogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
13 hours 53 minutes ago
Checkout newsWe're adding to our position in a sliding stock and booking profits in a 2025 winner
We're making a pair of trades Monday as Wall Street rallies to kick off the week.
2 days 13 hours ago
Checkout newsTrump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
2 days 16 hours ago
Checkout newsHims & Hers faces scrutiny from senators on Super Bowl ad that 'risks misleading' patients
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super Bowl ad.
5 days 8 hours ago
Checkout newsDoximity shares pop 36% on revenue beat, rosy guidance
The company built a digital platform for medical professionals that can help them carry out telehealth appointments with patients, find referrals and more.
5 days 9 hours ago
Checkout newsDoximity shares soar 25% after company beats on revenue, raises fiscal-year guidance
Doximity reported third-quarter fiscal 2025 results that beat analysts' expectations for revenue and guidance.
5 days 12 hours ago
Checkout newsAlphabet's Verily to sell Granular insurance business to Elevance Health
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health.
6 days 6 hours ago
Checkout newsEli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.
6 days 12 hours ago
Checkout newsEli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.
6 days 13 hours ago
Checkout newsBristol Myers' stock decline in response to weak guidance is a gift to investors
The heart of our investment thesis in the drugmaker remains intact.
6 days 14 hours ago
Checkout newsBristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company's older drugs face competition from cheaper generics.
6 days 16 hours ago
Checkout newsTeladoc Health to acquire Catapult Health in $65 million deal
At JPMorgan's health-care conference in January, Teladoc said it is actively working to grow membership and use of services within its integrated care segment.
1 week ago
Checkout newsNovo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.
1 week ago
Checkout newsHealthy Returns: Why people quit weight loss and diabetes drugs within one year
A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to focus on GLP-1 products.
1 week ago
Checkout newsTrump administration sued over FBI Jan. 6 questionnaires, FDA clinical data removal
One lawsuit accuses the DOJ of compiling retaliation lists. Another claims the CDC and other agencies deleted medical data that doctors relied upon.
1 week 1 day ago
Checkout newsIn 51 U.S. states are published
2222
Companies
850
Counties
1548
Cities
The 5 newest Companies
3525 Ross Clark Cir Ste 315, Dothan, AL 36303
6506 Lonetree Blvd, Rocklin, CA 95765
367 Russell St, Hadley, MA 01035
3 Tennis Dr, Shrewsbury, MA 01545
2020 Landstown Centre Wy, Virginia Beach, VA 23456
Other Companies
2203 9th St, Marble Falls, TX 78654
Golden Gate Park, Kennedy Drive & 6th Avenue, San Francisco, CA 94118
600 E Main St, Kingsport, TN 37660
5801 Valley Ave, Pleasanton, CA 94566
2649 Old Rocky Ridge Rd, Birmingham, AL 35216